BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 28839429)

  • 21. Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2.
    Maggiore G; Gonzales E; Sciveres M; Redon MJ; Grosse B; Stieger B; Davit-Spraul A; Fabre M; Jacquemin E
    J Hepatol; 2010 Nov; 53(5):981-6. PubMed ID: 20800306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate.
    Gonzales E; Grosse B; Schuller B; Davit-Spraul A; Conti F; Guettier C; Cassio D; Jacquemin E
    Hepatology; 2015 Aug; 62(2):558-66. PubMed ID: 25716872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis.
    Noe J; Kullak-Ublick GA; Jochum W; Stieger B; Kerb R; Haberl M; Müllhaupt B; Meier PJ; Pauli-Magnus C
    J Hepatol; 2005 Sep; 43(3):536-43. PubMed ID: 16039748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A progressive familial intrahepatic cholestasis type 2 mutation causes an unstable, temperature-sensitive bile salt export pump.
    Plass JR; Mol O; Heegsma J; Geuken M; de Bruin J; Elling G; Müller M; Faber KN; Jansen PL
    J Hepatol; 2004 Jan; 40(1):24-30. PubMed ID: 14672610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy.
    Keitel V; Vogt C; Häussinger D; Kubitz R
    Gastroenterology; 2006 Aug; 131(2):624-9. PubMed ID: 16890614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taurocholate transport by hepatic and intestinal bile acid transporters is independent of FIC1 overexpression in Madin-Darby canine kidney cells.
    Harris MJ; Kagawa T; Dawson PA; Arias IM
    J Gastroenterol Hepatol; 2004 Jul; 19(7):819-25. PubMed ID: 15209631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II.
    Wang L; Soroka CJ; Boyer JL
    J Clin Invest; 2002 Oct; 110(7):965-72. PubMed ID: 12370274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional rescue of an ABCB11 mutant by ivacaftor: A new targeted pharmacotherapy approach in bile salt export pump deficiency.
    Mareux E; Lapalus M; Amzal R; Almes M; Aït-Slimane T; Delaunay JL; Adnot P; Collado-Hilly M; Davit-Spraul A; Falguières T; Callebaut I; Gonzales E; Jacquemin E
    Liver Int; 2020 Aug; 40(8):1917-1925. PubMed ID: 32433800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic gene transfer of human aquaporin-1 improves bile salt secretory failure in rats with estrogen-induced cholestasis.
    Marrone J; Soria LR; Danielli M; Lehmann GL; Larocca MC; Marinelli RA
    Hepatology; 2016 Aug; 64(2):535-48. PubMed ID: 26999313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families.
    Strautnieks SS; Byrne JA; Pawlikowska L; Cebecauerová D; Rayner A; Dutton L; Meier Y; Antoniou A; Stieger B; Arnell H; Ozçay F; Al-Hussaini HF; Bassas AF; Verkade HJ; Fischler B; Németh A; Kotalová R; Shneider BL; Cielecka-Kuszyk J; McClean P; Whitington PF; Sokal E; Jirsa M; Wali SH; Jankowska I; Pawłowska J; Mieli-Vergani G; Knisely AS; Bull LN; Thompson RJ
    Gastroenterology; 2008 Apr; 134(4):1203-14. PubMed ID: 18395098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholestasis After Pediatric Liver Transplantation-Recurrence of a Progressive Familial Intrahepatic Cholestasis Phenotype as a Rare Differential Diagnosis: A Case Report.
    Prusinskas B; Kathemann S; Pilic D; Hegen B; Küster P; Keitel V; Häussinger D; Büscher R; Baba HA; Hoyer PF; Lainka E
    Transplant Proc; 2017 Sep; 49(7):1628-1633. PubMed ID: 28838453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retargeting of bile salt export pump and favorable outcome in children with progressive familial intrahepatic cholestasis type 2.
    Varma S; Revencu N; Stephenne X; Scheers I; Smets F; Beleza-Meireles A; Reding R; Roskams T; Sokal EM
    Hepatology; 2015 Jul; 62(1):198-206. PubMed ID: 25847299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment.
    Cheng Y; Freeden C; Zhang Y; Abraham P; Shen H; Wescott D; Humphreys WG; Gan J; Lai Y
    Biopharm Drug Dispos; 2016 Jul; 37(5):276-86. PubMed ID: 27059119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BSEP inhibition: in vitro screens to assess cholestatic potential of drugs.
    Kis E; Ioja E; Rajnai Z; Jani M; Méhn D; Herédi-Szabó K; Krajcsi P
    Toxicol In Vitro; 2012 Dec; 26(8):1294-9. PubMed ID: 22120137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
    Stieger B
    Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
    Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exon-skipping and mRNA decay in human liver tissue: molecular consequences of pathogenic bile salt export pump mutations.
    Dröge C; Schaal H; Engelmann G; Wenning D; Häussinger D; Kubitz R
    Sci Rep; 2016 Apr; 6():24827. PubMed ID: 27114171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bile salt excretion in skate liver is mediated by a functional analog of Bsep/Spgp, the bile salt export pump.
    Ballatori N; Rebbeor JF; Connolly GC; Seward DJ; Lenth BE; Henson JH; Sundaram P; Boyer JL
    Am J Physiol Gastrointest Liver Physiol; 2000 Jan; 278(1):G57-63. PubMed ID: 10644562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
    Davit-Spraul A; Fabre M; Branchereau S; Baussan C; Gonzales E; Stieger B; Bernard O; Jacquemin E
    Hepatology; 2010 May; 51(5):1645-55. PubMed ID: 20232290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.
    Stieger B; Fattinger K; Madon J; Kullak-Ublick GA; Meier PJ
    Gastroenterology; 2000 Feb; 118(2):422-30. PubMed ID: 10648470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.